Patents by Inventor Christopher M. G. Ohms

Christopher M. G. Ohms has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6595951
    Abstract: The present invention is directed to a closure system for an oral active agent delivery device. The device comprises an elongate tubular member having first and second ends. The closure system includes a deformable closure means adapted to allow delivery of the active agent upon deformation. The closure system prevents spillage and maintains the integrity of the dose within the device. In use, the closure system is deformed and separated from the second end of the tubular member, liquid is drawn up into the first end of the member, and the liquid and active agent are drawn out of the second end of the member and into the patient's mouth.
    Type: Grant
    Filed: May 19, 2000
    Date of Patent: July 22, 2003
    Assignee: Alza Corporation
    Inventors: Patrick S. -L. Wong, James Horvath, Radomir N. M. Vukadin, Joyce C. Anthony, Vincent J. Ferrari, Jeffrey W. Etter, Christopher M. G. Ohms
  • Patent number: 6224908
    Abstract: Oral active agent delivery system having improved flow controllers. A hollow tubular member containing the active agent formulation and having a fluid passing controller is placed at one end into a fluid and at a second end into a patient's mouth. The active agent is delivered when the patient sips on the end of the chamber. The improved controllers prevent leakage of the active agent formulation.
    Type: Grant
    Filed: May 24, 2000
    Date of Patent: May 1, 2001
    Assignee: Alza Corporation
    Inventors: Patrick S.-L. Wong, Vincent J. Ferrari, Jeffrey W. Etter, Miriam A. Martin, Nathan Roth, Christopher M. G. Ohms, Andrew I. Poutiatine, James Horvath
  • Patent number: 6103265
    Abstract: The present invention is directed to an oral active agent delivery system comprising improved flow controllers. A hollow tubular member (10) containing the active agent formulation and having a fluid passing controller (14) is placed at one end (16) into a fluid and at a second end (18) into a patient's mouth. The active agent is delivered when the patient sips on the end of the chamber. The improved controllers prevent leakage of the active agent formulation.
    Type: Grant
    Filed: September 22, 1999
    Date of Patent: August 15, 2000
    Assignee: ALZA Corporation
    Inventors: Patrick S.-L. Wong, Vincent J. Ferrari, Jeffrey W. Etter, Miriam A. Martin, Nathan Roth, Christopher M. G. Ohms, Andrew I. Poutiatine, James Horvath
  • Patent number: 6096003
    Abstract: The present invention is directed to a closure system for an oral active agent delivery device. The device comprises an elongate tubular member having first and second ends. The closure system includes a deformable closure means adapted to allow delivery of the active agent upon deformation. The closure system prevents spillage and maintains the integrity of the dose within the device. In use, the closure system is deformed and separated from the second end of the tubular member, liquid is drawn up into the first end of the member, and the liquid and active agent are drawn out of the second end of the member and into the patient's mouth.
    Type: Grant
    Filed: October 14, 1997
    Date of Patent: August 1, 2000
    Assignee: ALZA Corporation
    Inventors: Patrick S.-L. Wong, James Horvath, Radomir N. M. Vukadin, Joyce C. Anthony, Vincent J. Ferrari, Jeffrey W. Etter, Christopher M. G. Ohms
  • Patent number: 5985324
    Abstract: The present invention is directed to an oral active agent delivery system comprising improved flow controllers. A hollow tubular member (10) containing the active agent formulation and having a fluid passing controller (14) is placed at one end (16) into a fluid and at a second end (18) into a patient's mouth. The active agent is delivered when the patient sips on the end of the chamber. The improved controllers prevent leakage of the active agent formulation.
    Type: Grant
    Filed: May 7, 1998
    Date of Patent: November 16, 1999
    Assignee: ALZA Corporation
    Inventors: Patrick S.-L. Wong, Vincent J. Ferrari, Jeffrey W. Etter, Miriam A. Martin, Nathan Roth, Christopher M. G. Ohms, Andrew I. Poutiatine, James Horvath